Norway Extends AstraZeneca Vaccine Suspension For Another 3 Weeks

Norway Extends AstraZeneca Vaccine Suspension For Another 3 Weeks

Norway Extends AstraZeneca Vaccine Suspension For Another 3 Weeks. image: AstraZeneca media

Norway Extends AstraZeneca Vaccine Suspension For Another 3 Weeks.

Norway has extended it’s ban on the use of AstraZeneca’s COVID-19 vaccine until April 15, the Norwegian Institute of Public Health (FHI) has said, amid continuing fears over blood clots.

The Norwegian authorities suspended the rollout of the vaccine on March 11 after a small number of younger inoculated people were hospitalised for a combination of blood clots, bleeding and a low count of platelets, some of whom later died.

The World Health Organization (WHO) has continued to urge countries to carry on using the vaccine, saying the benefits outweigh any potential risks. The European Medicines Agency (EMA) has also declared the shot “safe and effective”.

“It is a difficult but correct decision to extend the pause for the AstraZeneca vaccine,” Geir Bukholm, Director of the Division of Infection Control at the FHI, said in a statement on Friday. “We believe it is necessary to carry out more investigations into these cases.”

Norway is one of more than a dozen European countries to have suspended the rollout of the vaccine, although most have since resumed its use on the advice of the EMA. The shot remains on hold in Denmark, however, while other Nordic countries are just using it for older age groups.

It is still mandatory to wear masks during the pandemic, Amazon has a great range in stock, click on the link to see what they have on offer. https://amzn.to/3826Rmr


Thank you for taking the time to read this news article “Norway Extends AstraZeneca Vaccine Suspension For Another 3 Weeks”. For more UK daily news, Spanish daily news and Global news stories, visit the Euro Weekly News home page.

Author badge placeholder
Written by

Tony Winterburn

Share your story with us by emailing newsdesk@euroweeklynews.com, by calling +34 951 38 61 61 or by messaging our Facebook page www.facebook.com/EuroWeeklyNews

Comments